Literature DB >> 30500069

Risk factors for hepatocellular carcinoma.

Shih-Wei Lai1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30500069     DOI： 10.1002/cncr.31802

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Design, Synthesis, and Apoptosis-Promoting Effect Evaluation of Rhopaladins' Analog 4-Arylidene-5-Oxopyrrolidine Derivatives.

Authors:  Jun Zhu; Ling-Qi Kong; Qin-Hua Chen; Bin Li; Lun Wu; Feng-Ying Ran; Li-Na Ke; Xiao-Hua Zeng; Hong-Mei Wang
Journal:  Front Chem       Date:  2022-05-18       Impact factor: 5.545

Review 2.  Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.

Authors:  A Weinmann; P R Galle
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.